FHI files Form 144 to sell 14,000 common shares

FHI filed a Form 144 reporting a proposed sale of 14,000 shares of common stock with an aggregate offering price of $773,544.80.

Rhea-AI Filing Summary

FHI filed a Form 144 reporting a proposed sale of 14,000 shares of common stock with an aggregate offering price of $773,544.80. The notice lists vested restricted-stock lots issued for services on several dates, including 2,616 (11/18/2024), 2,389 (03/06/2023), 2,895 (11/16/2022), 2,224 (03/04/2024), 1,106 (11/16/2021), and 2,770 (11/17/2023).

Insights

Securities Counsel

Form 144 notifies regulators of a proposed resale of restricted common shares totaling 14,000 shares.

The filing names Raymond James & Associates and shows an aggregate offering price of $773,544.80. It itemizes vested restricted-stock lots granted for services on multiple dates between 11/16/2021 and 11/18/2024.

Review settlement disclosures and any subsequent Form 4 or Form 5 for completion details and credited proceeds; subsequent SEC filings will report whether the proposed resale occurred and its mechanics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does FHI's Form 144 disclose about the sale?

The filing discloses a proposed resale of 14,000 common shares and an aggregate offering price of $773,544.80. It lists multiple vested restricted-stock lots granted for services on dates from 11/16/2021 to 11/18/2024.

Who is listed as the broker on FHI's Form 144?

The filing lists Raymond James & Associates as the broker-dealer associated with the proposed sale. The broker-dealer name appears alongside the securities and quantity information in the Form 144 notice.

Which restricted-stock lots are listed on the Form 144 for FHI?

The notice itemizes restricted-stock vesting grants including 2,616 (11/18/2024), 2,389 (03/06/2023), 2,895 (11/16/2022), 2,224 (03/04/2024), 1,106 (11/16/2021), and 2,770 (11/17/2023). These are reported as shares to be sold under the Form 144.

Does the Form 144 state proceeds recipient or sale mechanics for FHI?

The filing shows an aggregate offering price of $773,544.80 but does not allocate proceeds within the listed lines. The notice names the broker and the lots; any detailed sale mechanics would appear in subsequent filings documenting completion.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:55 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001352542
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FEDERATED HERMES, INC.
SEC File Number	001-14818
Address of Issuer	1001 LIBERTY AVENUE PITTSBURGH PENNSYLVANIA 15222
Phone	4122881900
Name of Person for Whose Account the Securities are To Be Sold	Novak Richard A
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	14000	773544.80	77546867	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/18/2024	Restricted stock vesting under a registered plan	Issuer			2616	11/18/2024	Services rendered
Common	03/06/2023	Restricted stock vesting under a registered plan	Issuer			2389	03/06/2023	Services rendered
Common	11/16/2022	Restricted stock vesting under a registered plan	Issuer			2895	11/16/2022	Services rendered
Common	03/04/2024	Restricted stock vesting under a registered plan	Issuer			2224	03/04/2024	Services rendered
Common	11/16/2021	Restricted stock vesting under a registered plan	Issuer			1106	11/16/2021	Services rendered
Common	11/17/2023	Restricted stock vesting under a registered plan	Issuer			2770	11/17/2023	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Richard A. Novak
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)